-
25 drugs at Mark Cuban's online pharmacy with biggest cost reductions
06 Apr 2024 00:30 GMT
… Drugs now sells hundreds of generics and about 20 branded medications … pharmacy benefit managers.
Each drug is priced at its … medications with the biggest price cuts sold at Cost Plus Drugs …
Savings: $3,539.50
Lapatinib ditosylate (generic for Tykerb)
…
-
Combining Drugs and Radiation in Breast Cancer: What's Safe?
14 Mar 2024 11:02 GMT
… School of Medicine, Indianapolis, Indiana.
If trials evaluating … radiotherapy and systemic treatments in breast cancer. … radiotherapy in clinical trial setting
PARP inhibitors … HER2 drugs trastuzumab (Herceptin), pertuzumab (Perjeta), and lapatinib (Tykerb …
-
Combinatorial CRISPR screen reveals FYN and KDM4 as targets for synergistic drug combination for treating triple negative breast cancer
29 Feb 2024 19:49 GMT
… (3, 4). However, several clinical trials investigating TKIs, such as VEGFR … changes in signal transduction upon drug treatment. Compensatory activation of mitogenic signals … (e.g., lapatinib, a HER2 inhibitor) and chemotherapy drugs (e.g., irinotecan …
-
Antibody-Drug Conjugates in Breast Cancer: A Comprehensive Review of How to Selectively Deliver Payloads
28 Feb 2024 09:00 GMT
… and dual-drug ADCs. Probody-drug conjugates are … after neoadjuvant treatment, the KATHERINE trial revealed a … from five prospective trials investigating lapatinib and trastuzumab. Ann … 2024.
91. Sichuan Kelun Pharmaceutical Research Institute Co., Ltd …
-
Nanoparticles for the Treatment of Bone Metastasis in Breast Cancer: Recent Advances and Challenges
23 Feb 2024 13:20 GMT
… of drugs to tumors to enhance treatment efficacy, abrogate drug tolerance … et al164 proposed a pharmaceutical-organic-inorganic self-assembling … biological barriers to drug delivery. Nat Biotechnol. 2015;33 … II study evaluating lapatinib in combination with nab …
-
Advancing Pharmacists’ Role in Personalized Treatment for Breast, Prostate, and Lung Cancer
22 Feb 2024 14:19 GMT
… treatments to minimize adverse reactions. The labeling of many FDA-approved anticancer drugs … Perjeta; Genentech), and lapatinib (Tykerb; GSK), each … , including therapeutic vaccines, immunomodulators, autologous … and precision medicine. Trends Biotechnol. 2020; …
-
Menarini Silicon Biosystems announces publication of the DETECT III trial results highlighting the potential clinical utility of HER2 testing in circulating tumor cells with CELLSEARCH
09 Jan 2024 12:38 GMT
… treatment arm with reference HER2-targeted TKI (Tyrosine Kinase Inhibitor) lapatinib … Food & Drug Administration (FDA) for detecting … the China National Medical Products Administration … a multinational pharmaceutical, biotechnology and diagnostics company …
-
Lapatinib Increases Overall Survival in Metastatic Breast Cancer Patients With HER2-Positive Circulating Tumor Cells
05 Jan 2024 05:45 GMT
… study shows that lapatinib, a drug used for the treatment of metastatic HER2 … at various intervals during the trial.
No significant differences were found … randomized clinical trials."
About the Association for Diagnostics & Laboratory Medicine (ADLM …
-
Advances in HER2-Targeted Treatment for Advanced/Metastatic Urothelial Carcinoma.
01 Jan 2024 10:27 GMT
… have been found. Trials involving trastuzumab, pertuzumab, lapatinib, afatinib, and neratinib … mUC, and a clinical trial on T-DM1 (trastuzumab … However, a phase II trial showed that RC48-ADC was … mUC used in recent clinical trials.
Bladder (San Francisco, Calif …
-
Natco Pharma Limited Completes Transition of DASH Pharmaceuticals into Natco Pharma USA, Furthering Strategic Presence in the United States
02 Jan 2024 13:21 GMT
… markets, sells, and distributes generic pharmaceutical products, has officially transitioned to … Tablets, Everolimus Tablets, and Lapatinib Tablets. These launches have firmly … Dosage Formulations (FDF) and Active Pharmaceutical Ingredients (APIs) with a …